Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Six Months Ended June 30, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	5,309,477		$	—		$	—	$	5,309,477
Provision for uncollectible accounts	(23,861		)	—			—		(23,861		)
Net patient service operating revenues	5,285,616			—			—		5,285,616
Other revenues	450,781			—			—		450,781
Total net operating revenues	5,736,397			—			—		5,736,397
Operating expenses	4,887,519			—			—		4,887,519
Operating income	848,878			—			—		848,878
Debt expense, including refinancing charges	(233,208		)	—			—		(233,208		)
Other income	6,576			—			—		6,576
Income tax expense	154,605			—			—		154,605
Net income from continuing operations	467,641			—			—		467,641
Net income from discontinued operations, net of tax	63,910			16,466			323		47,121
Net income	531,551			16,466			323		514,762
Less: Net income attributable to noncontrolling interests	(85,589		)	(8,544		)	—		(77,045		)
Net income attributable to DaVita Inc.	$	445,962		$	7,922		$	323	$	437,717


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Six Months Ended June 30, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	531,551		$	16,466		$	323	$	514,762
Other comprehensive loss	(26,792		)	—			—		(26,792		)
Total comprehensive income	504,759			16,466			323		487,970
Less: Comprehensive income attributable to the noncontrolling interests	(85,589		)	(8,544		)	—		(77,045		)
Comprehensive income attributable to DaVita Inc.	$	419,170		$	7,922		$	323	$	410,925


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of June 30, 2018	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	389,264	$	—	$	—	$	389,264
Restricted cash and equivalents	90,884		—		—		90,884
Accounts receivable, net	1,842,108		—		—		1,842,108
Other current assets	710,025		—		—		710,025
Current assets held for sale	6,053,081		524,595		3,056		5,525,430
Total current assets	9,085,362		524,595		3,056		8,557,711
Property and equipment, net	3,229,098		—		—		3,229,098
Amortizable intangibles, net	100,255		—		—		100,255
Other long-term assets	342,290		—		—		342,290
Goodwill	6,678,559		—		—		6,678,559
Total assets	$	19,435,564	$	524,595	$	3,056	$	18,907,913
Current liabilities	$	3,512,414	$	—	$	—	$	3,512,414
Current liabilities held for sale	1,271,364		334,091		—		937,273
Payables to parent	—		56,761		3,056		(59,817		)
Long-term debt and other long-term liabilities	9,120,121		—		—		9,120,121
Noncontrolling interests subject to put provisions	1,047,158		—		—		1,047,158
Total DaVita Inc. shareholders’ equity	4,279,184		133,743		—		4,145,441
Noncontrolling interests not subject to put provisions	205,323		—		—		205,323
Shareholders’ equity	4,484,507		133,743		—		4,350,764
Total liabilities and shareholder’s equity	$	19,435,564	$	524,595	$	3,056	$	18,907,913


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Six Months Ended June 30, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	531,551		$	16,466		$	323		$	514,762
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	393,024			101,201			(323		)	292,146
Net cash provided by (used in) operating activities	924,575			117,667			—			806,908
Cash flows from investing activities:
Additions of property and equipment	(473,977		)	(2,097		)	—			(471,880		)
Acquisitions	(89,465		)	—			—			(89,465		)
Proceeds from asset and business sales	116,241			—			—			116,241
Investments and other items	23,137			(1,021		)	—			24,158
Net cash used in investing activities	(424,064		)	(3,118		)	—			(420,946		)
Cash flows from financing activities:
Long-term debt	573,981			—			—			573,981
Intercompany	—			57,783			—			(57,783		)
Other items	(879,890		)	—			—			(879,890		)
Net cash (used in) provided by financing activities	(305,909		)	57,783			—			(363,692		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3,473		)	—			—			(3,473		)
Net increase in cash, cash equivalents and restricted cash	191,129			172,332			—			18,797
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations	229,901			172,332			—			57,569
Net decrease in cash, cash equivalents and restricted cash from continuing operations	(38,772		)	—			—			(38,772		)
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	518,920			—			—			518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	480,148		$	—		$	—		$	480,148


(1)	After elimination of the unrestricted subsidiaries and the physician groups.